Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 58,500
-3,500 (-5.65%)
Last updated: May 20, 2026, 2:10 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 439.46 billion as of May 19, 2026.
Market Cap
439.46B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
58,500.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 439.46B, an increase of 95.70%. That is a compound annual growth rate of 302.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 461.02B | 18.10% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEXTEEL | 492.22B |
| K Car | 489.18B |
| Samsung FN REIT | 484.39B |
| BGF Co., Ltd. | 467.06B |
| NICE Holdings | 466.01B |
| SOCAR | 464.06B |
| Samchully Co.,Ltd | 451.97B |
| Nongshim Holdings | 448.01B |